Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
about
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theCharacterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures.Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.Pharmacological treatment of acquired QT prolongation and torsades de pointes.Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy.Pharmacogenomics and acquired long QT syndrome.Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent.Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes.Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.Double jeopardy.Modulation of the QT interval duration in hypertension with antihypertensive treatment.Ventricular arrhythmia in patients with prolonged QT interval during liver transplantation: two cases report.The mechanism of atrial antiarrhythmic action of RSD1235.
P2860
Q28087002-0F5FEB17-44D1-4027-924C-DDDA27230609Q33157691-57746EBD-FBF5-443D-BCA2-18FB3919F533Q33161775-6F750FE6-11C1-48C5-8C1C-443147262740Q33166019-7C360F4C-D8B0-42EA-B8BE-712504428E22Q33563312-C879ED6E-AE1D-4B98-A2C4-DCE461EDB5BBQ36192679-40FE55CA-C691-44A2-9F56-D25C44F2E0EFQ36764028-BFB54081-EE21-4B6E-B187-99EEA6117B34Q36798015-653D5C0B-63E9-44D6-85BD-21D34E9F15B1Q36799533-13633F4C-7989-4EC7-9405-AF2BB6649B2BQ37143372-D323BBCC-60AA-4BFE-B5B1-B02CDC006066Q37388061-CAFE04C5-79C5-4A9A-9464-06961989AB03Q38383090-3335AA62-6C42-43D9-AF1B-17E8F1A29253Q42181634-A1F9C0C7-C998-4C5A-9124-DCDF966ADF3CQ42673854-771A25B8-54C2-4DF6-8BF0-50255E25A361
P2860
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@ast
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@en
type
label
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@ast
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@en
prefLabel
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@ast
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@en
P1476
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
@en
P2093
Ijaz A Khan
Ramesh M Gowda
P356
10.1016/J.IJCARD.2003.04.018
P577
2004-05-01T00:00:00Z